Scaly papule or warty growth, caused by five fungi, that spreads as a result of satellite lesions affecting the foot or leg. The extremity may become swollen and, at its distal portion, covered with various nodular, tumorous, verrucous lesions that resemble cauliflower. In rare instances, the disease may begin on the hand or wrist and involve the entire upper extremity. (Arnold, Odom, and James, Andrew's Diseases of the Skin, 8th ed, p362)
A mitosporic fungal genus. Phialophora verrucosa is a cause of chromomycosis (CHROMOBLASTOMYCOSIS). Ophiobolus is the teleomorph of Phialophora.
A phylum of fungi which have cross-walls or septa in the mycelium. The perfect state is characterized by the formation of a saclike cell (ascus) containing ascospores. Most pathogenic fungi with a known perfect state belong to this phylum.
A large and heterogenous group of fungi whose common characteristic is the absence of a sexual state. Many of the pathogenic fungi in humans belong to this group.
A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.
A normally saprophytic mitosporic Chaetothyriales fungal genus. Infections in humans include PHAEOHYPHOMYCOSIS; and PERITONITIS.. Exophiala jeanselmei (previously Phialophora jeanselmei) is an etiological agent of MYCETOMA.
An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. (From Dorland, 27th ed)
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.

Partial chemical characterization of antigenic preparations of chromoblastomycosis agents. (1/59)

Antigenic preparations (saline, methylic, metabolic and exoantigens) of four agents of chromoblastomycosis, Fonsecaea pedrosoi, Phialophora verrucosa, Cladophialophora (Cladosporium) carrionii and Rhinocladiella aquaspersa were obtained. Partial chemical characterization of these antigenic preparations was obtained by determination of the levels of total lipids, protein, and carbohydrates, and identification of the main sterols and carbohydrates. Methylic antigens presented the highest lipid contents, whereas metabolic antigens showed the highest carbohydrate content. Total lipid, protein, and carbohydrate levels were in the range of 2.33 to 2.00 mg/ml, 0.04 to 0.02 mg/ml and 0.10 to 0.02 mg/ml, respectively, in the methylic antigens and in the range of 0. 53 to 0.18 mg/ml, 0.44 to 0.26 mg/ml, and 1.82 to 1.02 mg/ml, respectively, in saline antigens. Total lipid, protein, and carbohydrate contents were in the range of 0.55 to 0.20 mg/ml, 0.69 to 0.57 mg/ml and 10.73 to 5.93 mg/ml, respectively, in the metabolic antigens, and in the range of 0.55 to 0.15 mg/ml, 0.62 to 0.20 mg/ml and 3.55 to 0.42 mg/ml, respectively, in the exoantigens. Phospholipids were not detected in the preparations. Saline and metabolic antigens and exoantigens presented hexose and the methylic antigen revealed additional pentose units in their composition. The UV light absorption spectra of the sterols revealed squalene and an ergosterol fraction in the antigens. The characterization of these antigenic preparations may be useful for serological evaluation of patients of chromoblastomycosis.  (+info)

Humoral immune response in chromoblastomycosis during and after therapy. (2/59)

A longitudinal study was carried out in Madagascar, the most important focus of chromoblastomycosis (P. Esterre, A. Andriantsimahavandy, E. Ramarcel, and J. L. Pecarrere, Am. J. Trop. Med. Hyg. 55:45-47, 1996), to investigate natural immunity to this disease. Sequential blood samples were obtained before, during, and at the end of a successful therapeutic trial with terbinafine, a new antifungal drug. Using enzyme-linked immunosorbent assay and immunoblot methods, detailed analyses of antibody concentration and antigen mapping were conducted for 136 serum samples and tentatively correlated to epidemiological and pathobiological data. Two different cytoplasmic antigens, corresponding to the two fungal species involved (Fonsecaea pedrosoi and Cladophialophora carrionii), were used to analyze the distribution of different classes of immunoglobulins. This was done with respect to the origin of the isolates, clinical and pathobiological. Although strong individual variations were noticed, some major antigens (one of 18.5 kDa specific for F. pedrosoi and two of 23.5 and 33 kDa, respectively, specific for C. carrionii) corresponded to high antibody prevalence and concentration. As some antigenic components were also detected by immunoglobulin M (IgM) and IgA antibodies, the role that these specific antibodies could play in the immune response is discussed.  (+info)

Dematiaceous fungal keratitis. Clinical isolates and management. (3/59)

Clinical and laboratory features of 16 cases of keratitis that were caused by dematiaceous pigmented fungi are reported. Management, including the treatment of nine cases with Natamycin (Pimaricin), resulted in corneal healing in 14 cases, and therapeutic surgery in two cases.  (+info)

A case of chromomycosis treated by a combination of cryotherapy, shaving, oral 5-fluorocytosine, and oral amphotericin B. (4/59)

A case of chromomycosis from Comoro Islands was first treated without success with high doses of oral amphotericin B (3 g per day). Treatment with itraconazole (400 mg per day) was also unsuccessful. Then, in vitro tests were done to study the susceptibility of this Fonsecaea pedrosoi strain to antifungal drugs. It was resistant to itraconazole, sensitive to 5-fluorocytosine, and the combination of 5-fluorocytosine with amphotericin B was synergistic. The patient was then treated with this last combination of drugs, which seemed to be effective. The patient stopped this treatment after six months, and relapse occurred two years later. The best therapeutic strategy in cases of chromomycosis seems to be a combination of two drugs chosen according to the results of prior antifungal susceptibility testing.  (+info)

Cerebral chromoblastomicosis--a rare case report of cerebral abscess and brief review of literature--a case report. (5/59)

A rare case of Cerebral Chromomycosis caused by chromogenic fungus Cladosporium trichoides in a 35 year old male with classical presentation of cerebral abscess is being presented. The case report lays emphasis on the histological diagnosis of chromogenic fungus in the wall of the abscess cavity, surgically removed from a well delineated circumscribed lesion in the frontal lobe of the cerebrum. The causative fungus could be detected even in unstained paraffin sections. The diagnosis could be made only after surgical removal and histopathological examination. The mycological culture could not be made as the material was received in formaldehyde fixative. The unique features of the case is its recurrence free uneventful survival five years after surgical excision. This is probably the fifth reported case of cerebral chromomycosis from India and first of its type from arid zone of Rajasthan.  (+info)

Chromoblastomycosis simulating rhinosporidiosis in a patient from Ceylon. (6/59)

A case of chromoblastomycosis confined to the mucous membrane of one side of the nasal septum is reported. The organism was not cultivated, but its characteristics in histological preparations were typical of those of the organisms in sections of cutaneous lesions known to be caused by Phialophora pedrosoi and related fungi. The diagnosis is considered to have been justified in spite of the great rarity of mucosal involvement in chromoblastomycosis and of the complete absence of lesions in the skin. The patient was a Sinhalese student working in London. He had first noticed the lesion before he left Ceylon, but the symptoms of nasal obstruction and bleeding were not sufficient to make him seek medical advice until two years later. If it is correct to assume that he contracted the infection in Ceylon his case is only the second on record in which there has been reason to suggest that Ceylon has been the geographical source of chromoblastomycosis. The lesion was excised and its site cauterized. There has been no sign of recurrence of the infection during the two years that have passed since the operation.  (+info)

Fonsecaea pedrosoi cerebral phaeohyphomycosis ("chromoblastomycosis"): first human culture-proven case reported in Brazil. (7/59)

Cerebral phaeohyphomycosis ("chromoblastomycosis") is a rare intracranial lesion. We report the first human culture-proven case of brain abscesses due to Fonsecaea pedrosoi in Brazil. The patient, a 28 year-old immunocompetent white male, had ocular manifestations and a hypertensive intracranial syndrome. Magnetic resonance imaging (MRI) of the brain revealed a main tumoral mass involving the right temporo-occipital area and another smaller apparently healed lesion at the left occipital lobe. A cerebral biopsy was performed and the pathological report was cerebral chromoblastomycosis. The main lesion was enucleated surgically and culture of the necrotic and suppurative mass grew a fungus identified as Fonsecaea pedrosoi. The patient had received a knife wound sixteen years prior to his hospitalization and, more recently, manifested a pulmonary granulomatous lesion in the right lung with a single non-pigmented form of a fungus present. It was speculated that the fungus might have gained entrance to the host through the skin lesion, although a primary respiratory lesion was not excluded. The patient was discharged from the hospital still with ocular manifestations and on antimycotic therapy and was followed for eight months without disease recurrence. Few months after he had complications of the previous neuro-surgery and died. A complete autopsy was performed and no residual fungal disease was found.  (+info)

Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes. (8/59)

Fonsecaea pedrosoi is a fungal pathogen that produces melanin. The functions of melanin and its possible influence in the protective immunological response during infection by F. pedrosoi are not known. In this work, treatment of F. pedrosoi mycelia with proteases and glycosidases followed by a denaturing agent and hot concentrated acid left a black residue. Scanning electron microscopy demonstrated that this processed melanized residue resembled very closely the intact mycelium in shape and size. Melanin particles were also isolated from culture fluids of conidia or sclerotic forms of F. pedrosoi. Secreted melanins were reactive with sera from infected human patients, suggesting that F. pedrosoi synthesizes melanin in vivo. The antibodies against melanin were purified from patients' sera and analyzed by indirect immunofluorescence. They reacted with sclerotic cells from patients' lesions as well as with sclerotic bodies cultivated in vitro, conidia, mycelia, and digested residues. Treatment of F. pedrosoi with purified antibodies against melanin inhibited fungal growth in vitro. The interaction of F. pedrosoi with phagocytes in the presence of melanin resulted in higher levels of fungal internalization and destruction by host cells, which was accompanied by greater degrees of oxidative burst. Taken together, these results indicate that melanin from F. pedrosoi is an immunologically active fungal structure that activates humoral and cellular responses that could help the control of chromoblastomycosis by host defenses.  (+info)

The fungi enter the body through traumatic inoculation or inhalation of spores, and may cause a chronic inflammatory response that leads to the formation of granulomas. The hallmark of chromoblastomycosis is the presence of histopathologically distinctive yeast-like structures called "chromoblasts" within the granulomas. These chromoblasts are typically blue-green or bluish-black in color due to the accumulation of melanin.

The clinical presentation of chromoblastomycosis can vary depending on the location and extent of the infection, but may include skin lesions, lymphadenopathy, fever, fatigue, and weight loss. Diagnosis is based on a combination of clinical findings, radiographic imaging (e.g., chest X-ray or CT scan), and histopathologic examination of tissue samples. Treatment typically involves surgical excision of affected tissues, antifungal therapy, and management of associated complications such as inflammation and fibrosis.

... is very rarely fatal.[citation needed] Chromoblastomycosis occurs around the world, most commonly in rural ... Chromoblastomycosis spreads very slowly.[citation needed] It is rarely fatal and usually has a good prognosis, but it can be ... Chromoblastomycosis is a long-term fungal infection of the skin and subcutaneous tissue (a chronic subcutaneous mycosis). It ... The prognosis for chromoblastomycosis is very good for small lesions. Severe cases are difficult to cure, although the ...
When present in skin or subcutaneous tissue, the cells are indicative of chromoblastomycosis. Apurba shastry review of ... "Chromoblastomycosis". Postepy Dermatol Alergol. 31 (5): 310-21. doi:10.5114/pdia.2014.40949. PMC 4221348. PMID 25395928. v t e ...
Silva-Hutner's work on chromoblastomycosis laid the groundwork for further research on this pathogen, which remains among the ... Silva-Hunter's work with Carrión focused on fungal infections, especially chromoblastomycosis. Silva-Hutner began attending ... Krzyściak, Paweł M.; Pindycka-Piaszczyńska, Małgorzata; Piaszczyński, Michał (October 2014). "Chromoblastomycosis". Advances in ...
F. compacta has the ability to cause a disease called Chromoblastomycosis. The five main causal fungi of chromoblastomycosis ... F. compacta is a rare etiological agent of chromoblastomycosis in humans, as it has only been reported in a few instances.[ ... Sharma, N. L.; Sharma, R. C.; Grover, P. S.; Gupta, M. L.; Sharma, A. K.; Mahajan, V. K. (1999). "Chromoblastomycosis in India ... Chromoblastomycosis is distributed worldwide, although it is more common in tropical and subtropical countries.[citation needed ...
... carrionii is a common cause of chromoblastomycosis in semi-arid climates. Some of the species are endophytes- ... Borelli, D. (1980). Causal agents of chromoblastomycosis (chromomycetes). Proceedings of the fifth International Conference on ...
Many cases of chromoblastomycosis cases target males over the age of thirty because they are predominant in the agricultural ... Chromoblastomycosis results in subcutaneous, crusty lesions that can spread over large areas on different parts of the body ... Chromoblastomycosis infection occurs by subcutaneous puncture by a thorn or splinter that is infected with C. carrionii, such ... It is one of the most common agents of chromoblastomycosis. The fungus changes states once it invades the animal host from the ...
Yang, Y; Yongxuan, H; Zhang, J; Li, X; Lu, C; Xi, L; Xi, Liyan (2012). "A refractory case of chromoblastomycosis due to ... Farming activities in the endemic zone are a risk factor for the development of chromoblastomycosis. Fonsecaea is a genus of ... Farmers in Central and South America are most susceptible to chromoblastomycosis due to F. pedrosoi. Infection often occurs in ... The diagnosis and treatment of chromoblastomycosis by F. pedrosoi remains clinically challenging due to the relative rarity of ...
The muriform-like cells isolated from E. dermatitidis infections have thinner walls than those found in chromoblastomycosis, ... Kano K. (1934). "A new pathogenic Hormiscium Kunze causing chromoblastomycosis". Aichi Igakkai Zasshi (in Japanese). 41: 1657- ... cells that resemble those found in chromoblastomycosis. ...
Several, including sporotrichosis, chromoblastomycosis and mycetoma are neglected. A wide range of fungal infections occur in ... Subcutaneous types include eumycetoma and chromoblastomycosis, which generally affect tissues in and beneath the skin. Systemic ... ICD-11 codes include: 1F20 Aspergillosis 1F21 Basidiobolomycosis 1F22 Blastomycosis 1F23 Candidosis 1F24 Chromoblastomycosis ... chromoblastomycosis, and eumycetoma. Systemic fungal infections include histoplasmosis, cryptococcosis, coccidioidomycosis, ...
While the spread of chromoblastomycosis to the muscle and bone is usually rare, in cases where antifungal drugs alone are ... Cases of chromoblastomycosis, subcutaneous phaehyphomycosis, and cutaneous infections caused by P. verrucosa have been reported ... Hofmann, H; Choi, S. M.; Wilsmann-Theis, D.; Horre, R.; de Hoog, G. S. (2005). "Invasive chromoblastomycosis and sinusitis due ... Phialophora verrucosa is a pathogenic, dematiaceous fungus that is a common cause of chromoblastomycosis. It has also been ...
A case of chromoblastomycosis is effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato ...
Fungal infections may lead to chromoblastomycosis, blastomycosis, mucormycosis, and dermatophytosis. Other numerous arthropod, ...
nov, a new agent of human chromoblastomycosis revealed using molecular data". Medical Mycology. 48 (6): 800-806. doi:10.3109/ ... The type species, Fonsecaea pedrosoi, is associated with the disease chromoblastomycosis. Vicente VA, Orélis-Ribeiro R, ... "Rapid identification of Fonsecaea by duplex polymerase chain reaction in isolates from patients with chromoblastomycosis". ...
... arxii was seen in Australia with the patient suffering from a pulmonary chromoblastomycosis. Several anti fungal drugs have ... Features Consistent with Possible Primary Pulmonary Chromoblastomycosis". Am. J. Trop. Med. Hyg. 92 (4): 791-793. doi:10.4269/ ... "Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis". Antimicrobial ...
In this phase, it can be confused with fungal infections such as blastomycosis and chromoblastomycosis.[citation needed] The ...
It can also be used for the treatment of chromomycosis (chromoblastomycosis), if susceptible strains cause the infection. ...
... marneffei and chromoblastomycosis; and prophylaxis of histoplasmosis and infections caused by T. marneffei in AIDS patients. ...
Chromoblastomycosis and other deep mycoses, scabies and other ectoparasites, and snakebite envenomation were added to the list ...
Symptoms include lesion, pus, thickening of skin, and chromoblastomycosis-like, muriform bodies-less tumorous mass, which makes ...
... chromoblastomycosis, and eumycetoma. Previous instances of onychomycosis had been previously traced to E. dermatiditis and E. ...
... piedra Candidal intertrigo Candidal onychomycosis Candidal paronychia Candidal vulvovaginitis Candidid Chromoblastomycosis ( ...
... chromoblastomycosis MeSH C01.539.800.200.500 - maduromycosis MeSH C01.539.800.200.600 - paracoccidioidomycosis MeSH C01.539. ... chromoblastomycosis MeSH C01.703.295.522 - maduromycosis MeSH C01.703.295.600 - paracoccidioidomycosis MeSH C01.703.295.675 - ...
... mycoses caused by Talaromyces marneffei and chromoblastomycosis; and prophylaxis of histoplasmosis and infections caused by T. ...
... chromoblastomycosis, and other deep mycoses Ectoparasitic infections Scabies and other ectoparasites Others Snakebite ...
Chromoblastomycosis), a fungal skin infection This disambiguation page lists articles associated with the title Pedroso. If an ...
... chromoblastomycosis MeSH C17.800.838.208.557 - maduromycosis MeSH C17.800.838.208.600 - paracoccidioidomycosis MeSH C17.800. ...
... chromoblastomycosis and can occasionally cause eumycetoma which is a chronic granulomatous disease in the form of black grains ...
Patients with chromoblastomycosis were older (47.9 years) than those without (37.5 years) (p = 0.0005). Chromoblastomycosis was ... Patients with Chromoblastomycosis. At the first consultation, 58 of 148 patients had clinically suspected chromoblastomycosis. ... Natural history of chromoblastomycosis in Madagascar and the Indian Ocean] [Natural history of chromoblastomycosis in ... Patients who had chromoblastomycosis were significantly older (47.9 years) than those without chromoblastomycosis (37.5 years ...
Chromoblastomycosis. *A fungal infection of the skin that develops over weeks or months. It usually begins when a fungus gets ... Queiroz-Telles F. Chromoblastomycosis: A Neglected Tropical Diseaseexternal icon. Revista do Instituto de Medicina Tropical de ... Krzyściak PM, Pindycka-Piaszczyńska M, Piaszczyński M. Chromoblastomycosisexternal icon. Advances in Dermatology and ...
Is there a cure for chromoblastomycosis?. Can chromoblastomycosis be cured?. How common is chromoblastomycosis?. ... Who discovered chromoblastomycosis?. The name "chromoblastomycosis" was employed for the first time in 1922 by Terra et al. to ... What fungus causes chromoblastomycosis?. The fungi most commonly reported as causing chromoblastomycosis are F pedrosoi, C ... How is chromoblastomycosis treated?. Although early, small lesions of chromoblastomycosis can be treated with surgical removal ...
Chromoblastomycosis is a disease caused by melanized fungi, primarily belonging to the genera Fonsecaea and Cladophialophora, ... Chromoblastomycosis is affecting the poor population in rural and urban areas, mainly related to agricultural activities, with ... Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Gros Molecular epidemiology and clinical- ... Patients diagnosed with chromoblastomycosis treated at the Júlio Müller University Hospital, Cuiabá, Brazil, from January 2015 ...
Chromoblastomycosis of the conjunctiva mimicking melanoma of the ciliary body.. Anh Q Bui, Edgar M Espana, Curtis E Margo. ...
chromoblastomycosis* In chromoblastomycosis. …local injection of the antibiotic amphotericin B. Extensive disease may require ...
Mycobacterium marinum is an atypical Mycobacterium found in salt water and fresh water. M marinum is the most common atypical Mycobacterium to cause infection in humans.
Chromoblastomycosis [‎1]‎. Chromogenic Compounds [‎1]‎. Chromosome Aberrations [‎5]‎. Chromosome Deletion [‎1]‎. Chromosomes [‎ ...
Categories: Chromoblastomycosis Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, CopyrightRestricted ...
Dermatology, Skin Diseases, Actinomycosis, Chromoblastomycosis, Sporotrichosis, Leprosy, Leprosy, Borderline, Leprosy, ...
Chromoblastomycosis Whats New Last Posted: Jan 01, 2011 * Chromoblastomycosis From NCATS Genetic and Rare Diseases Information ...
Chromoblastomycosis - Preferred Concept UI. M0004392. Scope note. Scaly papule or warty growth, caused by five fungi, that ...
Chromoblastomycosis 293. Chronic pernio 294. Chronic venous insufficiency 295. Cierny-Mader 296. Cimetidine 297. Ciprofloxacin ...
Eumycetoma, chromoblastomycosis, and disseminated infections were excluded. Results. Eighteen cases were analyzed. The median ...
Flucytosine is not employed as the sole therapy except occasionally in chromoblastomycosis. Rapid development of resistance ...
... chromoblastomycosis, o paracoccidioidomycosis. Puntuación 3.9 estrellas, basado en 212 comentarios.. Precio desde €1.74 por ...
Subcutaneous mycoses are the result of implantation and include chromoblastomycosis, mycetoma, sporotrichosis, ...
This investigation revealed the saprophytic existence of species known as agents of chromoblastomycosis and phaeohyphomycosis. ... Herpotrichiellaceous fungi, common agents of chromoblastomycosis and phaeohyphomycosis, were searched in samples of rotten wood ...
Treatment of infections caused by fungi that cause the conditions known as "chromoblastomycosis" and "mycetoma" that have not ...
Chromoblastomycosis 111730=Aspergillosis 111740=Mycotic mycetomas 111750=Cryptococcosis 111760=Allescheriosis [ ...
... and so the account of Chromoblastomycosis kinases that phosphorylate them will likely differ from the endogenous proteins from ...
This field is for validation purposes and should be left unchanged ...
Chromoblastomycosis) · Geotrichum candidum (Geotrichosis) · Pseudallescheria boydii (Allescheriasis) ...
  • As is the case for other implantation mycoses, chromoblastomycosis lesions are located mainly on the lower limbs, particularly on the dorsal face of the feet, ankles, and legs ( 1 , 4 - 6 ). (cdc.gov)
  • The inoculation mycoses sporotrichosis, chromoblastomycosis and eumycetoma occur occasional y (with 40, 40 and 10 cases estimated, respectively). (who.int)
  • Severe chromoblastomycosis frequently is refractory to treatment. (britannica.com)
  • Chromoblastomycosis is a chronic, implantation, fungal disease caused by melanized fungi from a variety of genera of the order Chaetothyriales. (cdc.gov)
  • Chromoblastomycosis is a disease caused by melanized fungi , primarily belonging to the genera Fonsecaea and Cladophialophora, mainly affecting individuals who are occupationally exposed to soil and plant products. (bvsalud.org)
  • Treatment of infections caused by fungi that cause the conditions known as "chromoblastomycosis" and "mycetoma" that have not improved even with treatment with itraconazole. (mrmed.in)
  • Chromoblastomycosis is an implantation fungal infection. (cdc.gov)
  • Although early, small lesions of chromoblastomycosis can be treated with surgical removal, long-term oral antifungal therapy is the treatment of choice for more extensive disease. (blfilm.com)
  • Eumycetoma, chromoblastomycosis, and disseminated infections were excluded. (pasteur.fr)
  • Treatment of Chromoblastomycosis Itraconazole is the most effective drug for chromoblastomycosis, although not all patients respond. (blfilm.com)
  • All isolates had low MICs for itraconazole , voriconazole and terbinafine , confirming their importance as therapeutic alternatives for chromoblastomycosis . (bvsalud.org)
  • The clinical manifestation of chromoblastomycosis is polymorphous but is dominated by verrucous and tumoral lesions resembling cauliflower. (cdc.gov)
  • Chromoblastomycosis was 3 times more likely to consist of leg lesions (p = 0.003). (cdc.gov)
  • What is the type of lesions mostly seen in chromoblastomycosis? (blfilm.com)
  • Muriform cells are specific to chromoblastomycosis and described as large brown, thick-walled, compartmented cells. (cdc.gov)
  • Chromoblastomycosis still is a therapeutic challenge for clinicians due to the recalcitrant nature of the disease, especially in the severe clinical forms. (blfilm.com)
  • Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil. (bvsalud.org)
  • This research aimed to determine the clinical, epidemiological and laboratory characteristics of chromoblastomycosis in the state of Mato Grosso, Brazil . (bvsalud.org)
  • Chromoblastomycosis was diagnosed in 50 (33.8%) of 148 patients. (cdc.gov)
  • Patients with chromoblastomycosis were older (47.9 years) than those without (37.5 years) (p = 0.0005). (cdc.gov)
  • Patients diagnosed with chromoblastomycosis treated at the Júlio Müller University Hospital , Cuiabá, Brazil , from January 2015 to December 2020, whose isolates were preserved in the Research Laboratory of the Faculty of Medicine of the Federal University of Mato Grosso. (bvsalud.org)
  • Which is the effective treatment for chromoblastomycosis? (blfilm.com)
  • Characteristics of population affected by chromoblastomycosis. (blfilm.com)
  • Chromoblastomycosis is affecting the poor population in rural and urban areas , mainly related to agricultural activities, with F. pedrosoi being the dominant aetiologic agent. (bvsalud.org)
  • Flucytosine is not employed as the sole therapy except occasionally in chromoblastomycosis. (pharmacy180.com)
  • Severe systemic fungal infections with susceptible pathogens, as an alternative or when switching from parenteral use, particularly: candidiasis, cryptococcosis, chromoblastomycosis and certain forms of aspergillosis. (who.int)
  • Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. (medscape.com)
  • The clinical manifestation of chromoblastomycosis is polymorphous but is dominated by verrucous and tumoral lesions resembling cauliflower. (cdc.gov)
  • [ 53 ] The latter may develop in chronic chromoblastomycosis. (medscape.com)
  • Chromoblastomycosis is a chronic, implantation, fungal disease caused by melanized fungi from a variety of genera of the order Chaetothyriales. (cdc.gov)
  • Natural history of chromoblastomycosis in Madagascar and the Indian Ocean] [Natural history of chromoblastomycosis in Madagascar and the [Natural history of chromoblastomycosis in Madagascar and the Indian Ocean]. (nih.gov)
  • Chromoblastomycosis of the conjunctiva may be suggestive of a melanoma. (medscape.com)
  • Chromoblastomycosis and related dermal infections caused by dematiaceous fungi. (medscape.com)
  • Chromoblastomycosis by Cladophialophora carrionii associated with squamous cell carcinoma and review of published reports. (nih.gov)
  • Naka W, Harada T, Nishikawa T, Fukushiro R. A case of chromoblastomycosis: with special reference to the mycology of the isolated Exophiala jeanselmei. (medscape.com)
  • Piepenbring M, Caceres Mendez OA, Espino Espinoza AA, Kirschner R, Schofer H. Chromoblastomycosis caused by Chaetomium funicola: a case report from Western Panama. (medscape.com)